TTX-MC-138

N/A

Report date: 2024/03/26 16:18:31
NME

Base Information

Drug NameTTX-MC-138
Drug Alias NameTTX-MC-138TTX-MC138
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionCell death stimulantsMicroRNA 10b inhibitors
TargetsMicroRNA 10b
Therapy Area/IndicationsSolid tumoursPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTransCode Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTransCode Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A